Blood, antisera, vaccines, toxins and cultures in Switzerland 2020 Exports | Imports : $30.2B | $11.8B, World Rnk 3 / 193 Rnk 3 / 1208 | World Rnk 4 / 221 Rnk 3 / 1214
2019 - 2020 FASTEST GROWING MARKET | FASTEST GROWING ORIGIN: $1.2B | $711M, Germany | Japan
Exports In 2020, Switzerland exported $30.2B in Blood, antisera, vaccines, toxins and cultures, making it the 3rd largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 3rd most exported product in Switzerland. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Switzerland are: Germany ($5.95B), United States ($3.54B), China ($3.08B), Belgium ($1.63B), and Japan ($1.55B).
The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Switzerland between 2019 and 2020 were Germany ($1.2B), China ($1.01B), and Belgium ($301M).
Imports In 2020, Switzerland imported $11.8B in Blood, antisera, vaccines, toxins and cultures, becoming the 4th largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 3rd most imported product in Switzerland. Switzerland imports Blood, antisera, vaccines, toxins and cultures primarily from: Germany ($3.26B), Ireland ($2.64B), United States ($2.56B), Japan ($1.12B), and Belgium ($484M).
The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Switzerland between 2019 and 2020 were Japan ($711M), Germany ($631M), and Belgium ($198M).
For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.
The following visualization shows the latest trends on Blood, antisera, vaccines, toxins and cultures. Countries are shown based on data availability.
* Using January 2020 exchange rates when trade data is reported in local currency.
EXPORTS (2020): $30.2B
IMPORTS (2020): $11.8B
NET TRADE (2020): $18.4B
In 2020, Switzerland exported $30.2B in Blood, antisera, vaccines, toxins and cultures. The main destinations of Switzerland exports on Blood, antisera, vaccines, toxins and cultures were Germany ($5.95B), United States ($3.54B), China ($3.08B), Belgium ($1.63B), and Japan ($1.55B).
In 2020, Switzerland imported $11.8B in Blood, antisera, vaccines, toxins and cultures, mainly from Germany ($3.26B), Ireland ($2.64B), United States ($2.56B), Japan ($1.12B), and Belgium ($484M).
IN 2020, Switzerland HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:
IN 2020, Switzerland HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:
THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR Switzerland WERE (2019 - 2020):
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY Switzerland WERE (2019 - 2020):
In 2019, Switzerland's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:
In 2019, Switzerland's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:
In 2018, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of Switzerland were of 0% around the world.
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v5.1.8 ant